{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:35:54Z","timestamp":1794281754031,"version":"4.9.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Agence nationale de la recherche","award":["ANR-18-RHUS-0012"],"award-info":[{"award-number":["ANR-18-RHUS-0012"]}]},{"name":"Agence nationale de la recherche","award":["ANR-11-LABX-0042"],"award-info":[{"award-number":["ANR-11-LABX-0042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00415-022-11523-y","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T13:03:04Z","timestamp":1670936584000},"page":"1691-1701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques"],"prefix":"10.1007","volume":"270","author":[{"given":"Marco","family":"Vabanesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laurie","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Vogrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fabien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-3288","authenticated-orcid":false,"given":"Sergio","family":"Mu\u00f1iz-Castrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"11523_CR1","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1002\/cncr.21088","volume":"103","author":"B Vural","year":"2005","unstructured":"Vural B, Chen L-C, Saip P et al (2005) Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer 103:2575\u20132583. https:\/\/doi.org\/10.1002\/cncr.21088","journal-title":"Cancer"},{"key":"11523_CR2","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1073\/pnas.97.8.4198","volume":"97","author":"AO G\u00fcre","year":"2000","unstructured":"G\u00fcre AO, Stockert E, Scanlan MJ et al (2000) Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci USA 97:4198\u20134203. https:\/\/doi.org\/10.1073\/pnas.97.8.4198","journal-title":"Proc Natl Acad Sci USA"},{"key":"11523_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","volume":"165","author":"F Graus","year":"2005","unstructured":"Graus F, Vincent A, Pozo-Rosich P et al (2005) Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol 165:166\u2013171. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.03.020","journal-title":"J Neuroimmunol"},{"key":"11523_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","volume":"70","author":"L Sabater","year":"2008","unstructured":"Sabater L, Titulaer M, Saiz A et al (2008) SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 70:924\u2013928. https:\/\/doi.org\/10.1212\/01.wnl.0000281663.81079.24","journal-title":"Neurology"},{"key":"11523_CR5","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1200\/JCO.2008.20.6169","volume":"27","author":"MJ Titulaer","year":"2009","unstructured":"Titulaer MJ, Klooster R, Potman M et al (2009) SOX antibodies in small-cell lung cancer and lambert-eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol 27:4260\u20134267. https:\/\/doi.org\/10.1200\/JCO.2008.20.6169","journal-title":"J Clin Oncol"},{"key":"11523_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060438","volume":"8","author":"L Sabater","year":"2013","unstructured":"Sabater L, H\u00f6ftberger R, Boronat A et al (2013) Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer. PLoS ONE 8:e60438. https:\/\/doi.org\/10.1371\/journal.pone.0060438","journal-title":"PLoS ONE"},{"key":"11523_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jneuroim.2010.07.005","volume":"226","author":"M Tschernatsch","year":"2010","unstructured":"Tschernatsch M, Singh P, Gross O et al (2010) Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy. J Neuroimmunol 226:177\u2013180. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.07.005","journal-title":"J Neuroimmunol"},{"key":"11523_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jns.2016.09.002","volume":"369","author":"B Berger","year":"2016","unstructured":"Berger B, Dersch R, Ruthardt E et al (2016) Prevalence of anti-SOX1 reactivity in various neurological disorders. J Neurol Sci 369:342\u2013346. https:\/\/doi.org\/10.1016\/j.jns.2016.09.002","journal-title":"J Neurol Sci"},{"key":"11523_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jneuroim.2018.11.003","volume":"326","author":"P Maddison","year":"2019","unstructured":"Maddison P, Titulaer MJ, Verschuuren JJ et al (2019) The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders. J Neuroimmunol 326:14\u201318. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.11.003","journal-title":"J Neuroimmunol"},{"key":"11523_CR10","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000701","volume":"7","author":"B D\u00e9chelotte","year":"2020","unstructured":"D\u00e9chelotte B, Mu\u00f1iz-Castrillo S, Joubert B et al (2020) Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 7:e701. https:\/\/doi.org\/10.1212\/NXI.0000000000000701","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11523_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001014","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S et al (2021) Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11523_CR12","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1158\/1078-0432.CCR-10-1363","volume":"17","author":"CJ Chapman","year":"2011","unstructured":"Chapman CJ, Thorpe AJ, Murray A et al (2011) Immunobiomarkers in small cell lung cancer: potential early cancer signals. Clin Cancer Res 17:1474\u20131480. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1363","journal-title":"Clin Cancer Res"},{"key":"11523_CR13","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/dvdy.21218","volume":"236","author":"JC Kiefer","year":"2007","unstructured":"Kiefer JC (2007) Back to basics: sox genes. Dev Dyn 236:2356\u20132366. https:\/\/doi.org\/10.1002\/dvdy.21218","journal-title":"Dev Dyn"},{"key":"11523_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1600-0404.2011.01572.x","volume":"125","author":"O Stich","year":"2012","unstructured":"Stich O, Klages E, Bischler P et al (2012) SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes: SOX1 autoimmunity. Acta Neurol Scand 125:326\u2013331. https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01572.x","journal-title":"Acta Neurol Scand"},{"key":"11523_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3389\/fimmu.2019.00769","volume":"10","author":"R Ruiz-Garc\u00eda","year":"2019","unstructured":"Ruiz-Garc\u00eda R, Mart\u00ednez-Hern\u00e1ndez E, Garc\u00eda-Ormaechea M et al (2019) Caveats and pitfalls of SOX1 autoantibody testing with a commercial line blot assay in paraneoplastic neurological investigations. Front Immunol 10:769. https:\/\/doi.org\/10.3389\/fimmu.2019.00769","journal-title":"Front Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11523-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11523-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11523-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T13:09:16Z","timestamp":1677503356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11523-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["11523"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11523-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"9 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Observational studies conducted in France using data obtained from a retrospective study without any additional therapeutic or monitoring procedure do not require informed consent. Patient records and information were anonymized prior to analysis. The Institutional Review Board of the University Claude Bernard Lyon 1 and Hospices Civils de Lyon approved the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}